 | Up a level |
Carr-Wilkinson, Jane (2005) Aberrations of the p53/p14ARF/MDM2 pathway in neuroblastoma cell lines derived from progressive and/or relapsed tumours. In: American Association for Cancer Research, 2005, California, USA. (Submitted)
Gnanapragasam, VJ, Darby, Steven, Khan, M M, Lock, WG, Robson, CN and Leung, HY (2005) Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer. The Journal of Pathology, 206 (2). pp. 205-213. ISSN 0022-3417
Hardcastle, IR, Ahmed, Shafiq, Atkins, H, Calvert, AH, Curtin, NJ, Farnie, G, Golding, BT, Griffin, RJ, Guyenne, S, Hutton, C, Kallblad, P, Kemp, SJ, Kitching, MS, Newell, DR, Norbedo, S, Northen, JS, Reid, RJ, Saravanan, K, Willems, H and Lunec, J (2005) Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. Bioorganic & Medicinal Chemistry Letters, 15 (5). pp. 1515-1520.
Veuger, Stephany and Durkacz, B W (2005) PARP-1 function is essential for resistance to ionising radiation mediated by NFkB activation. Proceedings of the American Association for Cancer research, 2002 (181).
Visram, S, Crosland, Ann, Unsworth, John and Long, S (2005) Barriers and facilitators to engaging women from black and ethnic minority communities in cardiac rehabilitation(Abstract no. 127). Family Practice, 22 (supp.1). pp. 85-86. ISSN 0263-2136
Wilkes, Scott, Evans, A, Henderson, M and Gibson, J (2005) A Pragmatic observational study of the success of Bupropion for smoking cessation in one general practice. Post Graduate Medical Journal, 81 (961). pp. 719-722. ISSN 1469-0756